References
- Billing B H. Bilirubin metabolism. Diseases of the Liver, L Schiff, R S. Schiff. JB Lippincott, Philadelphia 1982; 349–68
- Klatskin G. Bile pigment metabolism. Ann Rev Med 1961; 12: 211–50
- Reichling J J., Kaplan M M. Clinical use of serum enzymes in liver disease. Dig Dis Sci 1988; 33: 1601–14
- Chiandussi L, Greene S F., Sherlock S. Serum alkaline phosphatase fractions in hepatobiliary and bone diseases. Clin Sci 1962; 22: 425–34
- Kaplan M. Alkaline phosphatase. Gastroenterology 1972; 62: 452–68
- DeRitis F, Coltorti M, Giusti G. Serum transaminase activities in liver disease. Lancet 1972; i: 685–87
- Matloff D S., Selinger M J., Kaplan M M. Hepatic transaminase activity in alcoholic liver disease. Gastroenterology 1980; 78: 1389–92
- Banks B M., Pineda E P., Goldbarg J A., Rutenburg A M. Clinical value of serum leucine aminopep-tidase determinations. N Engl J Med 1960; 263: 1277–81
- Bressler R, Forsyth B R., Klatskin G. Serum leucine aminopeptidase activity in hepatobiliary and pancreatic disease. J Lab Clin Med 1960; 56: 417–30
- Rutenberg A M., Goldbarg J A., Pineda E P. Serum gamma-glutamyl transpeptidase activity in hepatobiliary pancreatic disease. Gastroenterology 1963; 45: 43–8
- Rutenburg A M., Banks B M., Pineda E P., Goldbarg J A. A comparison of serum aminopeptidase and alkaline phosphatase in the detection of hepatobiliary disease in anicteric patients. Ann Intern Med 1964; 61: 50–5
- Pasanen P, Partanen K, Pikkarainen P, Alhava E, Pirinen A, Janatuinen E. Diagnostic accuracy of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the detection of obstructive jaundice. Scan J Gastroenterol 1991; 26: 1157–64
- The committee on enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology: Recommended methods for the determination of four enzymes in blood. Scand J Clin Lab Invest 1974; 33: 291–306
- Scandinavian Committee on Enzymes: Recommended method for the determination of g-Glutamyltransferase in blood. Scand J Clin Lab Invest 1976; 36: 119–125
- Feinstein A R. Clinical Epidemiology. The architecture of clinical research, A R. Feinstein. WB Saunders Company, Philadelphia 1985; 597–631
- Albert A. On the use and computation of likelihood ratios in clinical chemistry. Clin Chem 1982; 28: 1113–9
- Partanen K, Pikkarainen P, Pasanen P, Alhava E, Soimakallio S. Ultrasonography and computed tomography in diffuse liver disease with cholestasis. Acta Radiol 1990; 31: 477–82
- Pasanen P, Partanen K, Pikkarainen P, Alhava E, Pirinen A, Janatuinen E. Ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in diagnosis of choledochal stones. Acta Radiol 1992; 33: 53–6
- Pasanen P, Eskelinen M, Pikkarainen P, Alhava E, Partanen K, Penttila I. Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma. Br J Cancer 1992; 65: 731–734
- Roberts P J. The clinical value of tumour markers. Ann Chir Gynaecol 1986; 75: 247–248
- Stacker R, Ames B N. Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxides in bile. Proc Natl Acad Sci USA 1987; 84: 8130–34